How should individual participant data (IPD) from publicly funded clinical trials be shared?

Abstract

BackgroundIndividual participant data (IPD) from completed clinical trials should be responsibly shared to support efficient clinical research, generate new knowledge and bring benefit to patients. The Medical Research Council (MRC) Hubs for Trials Methodology Research (HTMR) has developed guidance to facilitate the sharing of IPD from publicly funded clinical trials.MethodsDevelopment of the guidance was completed over four phases which included a focussed review of policy documents, a web-based survey of the UK Clinical Research Collaboration (CRC) Registered Clinical Trials Units (CTU) Network, participation of an expert committee and an open consultation with the UKCRC Registered CTU Network. The project was funded by the MRC HTMR (MR/L004933/1-R39).ResultsGood practice principles include: (i) the use of a controlled access approach, using a transparent and robust system to review requests and provide secure data access; (ii) seeking consent for sharing IPD from trial participants in all future clinical trials with adequate assurance that patient privacy and confidentiality can be maintained; and (iii) establishing an approach to resource the sharing of IPD which would include support from trial funders, sponsor organisations and users of IPD. The guidance has been endorsed by Cancer Research UK, MRC Methodology Research Programme Advisory Group, Wellcome Trust and the Executive Group of the UKCRC Registered CTU Network. The National Institute for Health Research (NIHR) has confirmed it is supportive of the application of this guidance.ConclusionsImplementation of these principles will improve transparency, increase the coherent sharing of IPD from publicly funded trials, and help publicly funded trials to adhere to trial funder and journal requirements for data sharing.Electronic supplementary materialThe online version of this article (doi:10.1186/s12916-015-0532-z) contains supplementary material, which is available to authorized users.

The feasibility of early pulmonary rehabilitation and activity after COPD exacerbations: external pilot randomised controlled trial, qualitative case study and exploratory economic evaluation

“…Although specific consent for data sharing was not obtained, the management group will consider the release of data on a case-by-case basis following published guidelines. 195 The presented data do not contain any direct identifiers; we will minimise indirect identifiers and remove free-text data to minimise the risk of identification.…”

IMPACT Observatory: tracking the evolution of clinical trial data sharing and research integrity

“…Various key players are taking initiatives, holding discussions, producing statements and declaring policies regarding research data sharing ( 17 – 19 ). Many have contributed substantially to its increase, including the ICMJE, Ottawa statement, WHO, Cochrane, Declaration of Helsinki, the REWARD (REduce research Waste And Reward Diligence) Campaign, the Institute of Medicine report (IOM), and the AllTrials initiative ( 14 , 20 - 25 ).…”

Aquatic therapy for children with Duchenne muscular dystrophy: a pilot feasibility randomised controlled trial and mixed-methods process evaluation

“…Although specific consent for data sharing was not obtained, the management group will consider the release of data on a case-by-case basis following published guidelines. 278 The data presented do not contain any direct identifiers; we shall minimise indirect identifiers and remove free-text data to minimise the risk of identification. This protocol amendment was in relation to the following: it was clarified that the 6MWD should be completed only once at baseline and 26 weeks.…”